由美國病理學(xué)研究學(xué)會出版。ISSN: 1525 - 1578。《分子診斷,分子病理學(xué)協(xié)會的官方出版物、病理學(xué)調(diào)查的美國社會,尋求出版高質(zhì)量的原創(chuàng)論文翻譯和驗證的科學(xué)進(jìn)步分子的發(fā)現(xiàn)在醫(yī)學(xué)臨床診斷設(shè)置,和技術(shù)進(jìn)步的描述和應(yīng)用領(lǐng)域的分子診斷醫(yī)學(xué)。編輯歡迎評論文章,其中包括:直接應(yīng)用于臨床診斷或臨床病理相關(guān)性的新發(fā)現(xiàn),包括腫瘤學(xué)、傳染病、遺傳性疾病、疾病易感性或描述與疾病狀態(tài)或正常變異相關(guān)的多態(tài)性;診斷方法在臨床試驗中的應(yīng)用或開發(fā)新的或改進(jìn)的分子方法來診斷或監(jiān)測疾病或疾病易感性。
Published by American Society for Investigative Pathology. ISSN: 1525-1578.The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology, co-published by The American Society for Investigative Pathology, seeks to publish high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles which contain: novel discoveries with direct application to clinical diagnostics or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition.
SCI熱門推薦期刊 >
SCI常見問題 >
職稱論文常見問題 >
EI常見問題 >